Keyword: Sanofi

News

Sanofi Draws Fire Over Cost of MS Drug Lemtrada

01.11.2012 - Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...

News

Strong Refining Margins Boost Total Q3

31.10.2012 - French oil company Total reported a 20% rise in third-quarter net adjusted profit to €.348 billion on Wednesday, beating analysts' expectations thanks to a sharp increase in...

News

Sanofi Sees Relief from Patent Loss Pain

25.10.2012 - French drugmaker Sanofi forecast 2012 earnings would fall less than expected as cost cuts and demand for diabetes and rare disease drugs cushion the blow from patent expiries...

News

FDA Reviewers Spot Safety Concerns With Sanofi, Isis Lipid Drug

17.10.2012 - U.S. drug reviewers flagged several safety concerns, including possible cancer risks, related to Sanofi and Isis Pharmaceuticals's lipid disorder drug Kynamro, sending Isis's...

News

Sanofi, Bristol Shake up Alliance as Patents End

03.10.2012 - Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from Jan. 1 in response to lost exclusivity on two key drugs and the arrival of generic...

News

Sanofi to Buy Colombian Drugmaker Genfar

02.10.2012 - Giant French pharmaceutical maker Sanofi said Tuesday it would buy Colombian drugmaker Genfar to expand its product portfolio in South America. Genfar is Colombia's second-largest...

News

Sanofi Appoints Dr. Paul Chew Chief Medical Officer

01.10.2012 - Sanofi is pleased to announce today the appointment of Dr. Paul Chew, Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs as of January 1, 2013. Dr...

News

The European Pharmaceuticals Economy at Halftime 2012

25.09.2012 - A Pill a Day - Unlike chemicals, the pharmaceuticals sector does not have cycles. Even in a sluggish economy, sick people will still need medicine. But the widening European debt...